Company / Shares Outstanding
Ultragenyx Pharmaceutical Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
92.5M
FY2025
5-year range
66.8M / 92.5M
FY2021-FY2025
Trend
+12.4%
vs FY2024
Sector context
#106 of 212
Health Care
What the data says
At 92500000.00, Ultragenyx Pharmaceutical Inc.'s shares outstanding ranks #107 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 38882394.00 in FY2016 to 92500000.00 in FY2025.
Based on SEC 10-K filings.
92500000.00 in FY2025 with a 5-year CAGR of +9.8%.
Increased from 70197297.00 to 92500000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +10.1%
- 5-Year CAGR
- +9.8%
- 10-Year CAGR
- -
Sector benchmark
#107 of 212 in Health CareTop 50% of 212This company 92.5M Sector average 306.7M
▼
-69.8% below sector average
Key checks
Key Insights
- Ultragenyx Pharmaceutical Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 12.4% year-over-year.
- Ranks #106 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 92.5M | +12.4% |
| FY2024 | 82.3M | +17.3% |
| FY2023 | 70.2M | +1.2% |
| FY2022 | 69.3M | +3.8% |
| FY2021 | 66.8M | +15.5% |
| FY2020 | 57.8M | +13.7% |
| FY2019 | 50.9M | +15.2% |
| FY2018 | 44.2M | +7.1% |
| FY2017 | 41.2M | +6.1% |
| FY2016 | 38.9M | +5.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026